2024

1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

   AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

3. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

   Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

4. Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

   Ocular Immunology and Inflammation, Vol. 32, Núm. 9, pp. 2159-2169

5. Clinical guideline on adequacy and prescription of peritoneal dialysis

   Nefrologia, Vol. 44, pp. 1-29

6. Consenso AITP español: Una lista de verificación AITP

   Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, Vol. 37, Núm. 2, pp. 50-54

7. Consensus Report and Recommendations on the Management of Late-stage Internal Derangement of the Temporomandibular Joint

   Journal of Clinical Medicine, Vol. 13, Núm. 11

8. Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

   Rheumatology International, Vol. 44, Núm. 11, pp. 2327-2336

9. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

   Patient Preference and Adherence , Vol. 18, pp. 1163-1171

10. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

11. Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis

    Journal of Medical Economics, Vol. 27, Núm. 1, pp. 1379-1387

12. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology

13. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

14. Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 10, pp. 2591-2597

15. Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa

    The Journal of antimicrobial chemotherapy, Vol. 79, Núm. 11, pp. 3023-3028

16. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

17. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

18. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 10, pp. 1325-1338

19. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

20. Palliative care management in patients with Parkinson's disease and other movement disorders. National survey to neurologists

    Neurologia, Vol. 39, Núm. 5, pp. 417-425